NTHRYS › Internships › Ai Cancer Biology › AI Drug Resistance Mechanism Discovery Research

Metabolic Reprogramming Associated with Multi-Drug Resistance Phenotypes

Ai Cancer Biology

AI Drug Resistance Mechanism Discovery Research

Variant

Pay · Join

Step 4 of 5Select variant

Field

▾

Category

▾

Focused area

▾

You might prefer

Transcriptomic Profiling of Drug-Resistant Cancer Cell Populations Proteomic Analysis of Altered Signaling Pathway Activation Mechanisms Epigenetic Remodeling and Chromatin Accessibility in Resistant Phenotypes Single-Cell Heterogeneity Mapping in Chemotherapy Response Variation Machine Learning Models Predicting Acquired Resistance Trajectories Spatial Transcriptomics of Tumor Microenvironment Contributing to Resistance Extracellular Vesicle-Mediated Communication Networks in Resistance Propagation Mutational Landscape Evolution During Long-Term Drug Selection Pressure Artificial Intelligence-Driven Target Identification for Resistance-Dependent Vulnerabilities

Ai Cancer Biology › AI Drug Resistance Mechanism Discovery Research

Metabolic Reprogramming Associated with Multi-Drug Resistance Phenotypes

This research investigates altered metabolic pathways including glycolysis, oxidative phosphorylation, and lipid metabolism in resistant cancer cells using metabolomic profiling and isotope tracing. The findings demonstrate how metabolic flexibility enables cancer cells to survive in nutrient-depleted and drug-saturated microenvironments.

🎓 TYPE

🌐 MODE

⏱

📚 Academic: Thesis & PPT assistance included🧪 Tech: Master the protocols hands-on📝 Research > 3 months: Publication co-authorship in a Scopus-indexed journal

Select your preferenceChoose Type, Mode, Duration to view Titles

Internship Type

Mode

Duration

🎯

Choose your preferences above

Select Type, Mode and Duration to view available internship titles and fees.